Log in or create a free Rosenverse account to watch this video.
Log in Create free account100s of community videos are available to free members. Conference talks are generally available to Gold members.
Summary
Can a software only mobile solution outperform a pharmaceutical drug in clinical trials? Is it possible to create an app only available via a doctor’s prescription? The answer to both questions is a responding YES! In this webinar, Dan walked through several medical product case studies he has consulted on. The first is the WellDoc BlueStar solution for type 2 diabetes patients. BlueStar was the first instance of Digital Medicine invented. BlueStar received both an FDA class 2 certification and a prescription drug code for insurance reimbursement. Legally speaking this 100% software only solution is a medication. In clinical trials it has proven to reduce high-risk type 2 patients A1C levels by more than 1.8 points, outperforming many commonly prescribed medications. The second case study is Bigfoot Biomedical’s artificial pancreas for type 1 diabetics. It has completed its first clinical trial rounds but is not yet in the market. This solution uses an amazing combination of AI, big data and IoT embedded in the human body to automate insulin delivery 24/7. The primary UX resides on the patients’ phone. Interfaces for doctors and insurance companies will complete the end to end system experience including an innovative direct to patients supply chain. In addition to these amazing case studies this webinar described the similarities between digital medicine design and Enterprise UX. You will be surprised to see how much they have in common as well as what else you need to know to enter this cutting-edge UX domain.
Key Insights
-
•
Digital medicine apps like BlueStar are legally considered pharmaceutical products requiring prescriptions and FDA clearance, vastly differentiating them from typical health tracking apps.
-
•
Only about 0.01% of diabetes apps have FDA clearance ensuring accuracy and clinical efficacy.
-
•
BlueStar outperforms common pharmaceutical treatments like metformin by lowering A1C levels by two points through data science and behavioral coaching.
-
•
Bigfoot’s artificial pancreas is a closed hardware-software system with continuous glucose monitoring and insulin dosing, designed for type 1 diabetics.
-
•
Medical digital products require multi-persona design including patients, caregivers, doctors, payers, and pharmacies, forming a complex ecosystem.
-
•
Onboarding and provisioning involve drug prescription workflows integrated with insurance and pharmacy systems, with unique challenges like annual renewal and refill processes.
-
•
FDA regulation imposes rigorous human factors testing, traceability of design decisions, and documentation through a design history file not typically found in enterprise design.
-
•
Machine learning algorithms personalize insulin dosing in response to contextual data like location, activity, and environmental conditions such as altitude and temperature.
-
•
User retention in digital medicine can be paradoxically positive when users stop using the app because their health has improved, unlike typical app churn.
-
•
Designing regulated medical software demands far more patience and risk mitigation than enterprise UX, but mastering it allows one to succeed in less regulated domains.
Notable Quotes
"These are class of applications that are considered mobile prescription therapy."
"The line between regulated and unregulated is actually pretty simple in theory: if a product generates a diagnosis or treats, it's subject to FDA regulation."
"BlueStar can’t turn off your phone in an emergency state if you’re at risk of hypoglycemia—it essentially harasses you to take carbs."
"The insurance company won’t pay if the patient isn’t using BlueStar enough during the month; it’s a shared risk business model."
"You have to design for an ecosystem of experiences: patient, caregiver, doctor, payer, pharmacy, including complex refill and renewal workflows."
"The FDA approved agile process is closer to waterfall, with strong documentation and traceability requirements."
"If you can do medical product design, you can do anything. It’s the hardest UX domain."
"Most type 2 diabetics are treated by general practitioners, not endocrinologists, complicating education and adoption."
"It took about 10 years for BlueStar to develop a product that could charge money and scale with proven clinical results."
"Bigfoot’s pump algorithms run on the device itself so losing the phone doesn’t stop insulin dosing."
Or choose a question:
More Videos
"The consequences of inaction are not hypothetical; they are happening right now."
Alex Hurworth Bonnie John Fahd Arshad Antoine MarinDesigning a Contact Tracing App for Universal Access
October 23, 2020
"It’s really okay if this new position on your team is short-term only; we can provide the initial opportunity to get started on their career paths."
Laine Riley Prokay Lisa GordonCarving a Path for Early Career DesignOps Practitioners
September 9, 2022
"We stopped talking about patterns and consistency and started talking about scalability and speed to connect with stakeholders."
Eniola OluwoleLessons From the DesignOps Journey of the World's Largest Travel Site
October 24, 2019
"Tell tight, brief stories of insights focused on impact, not on how you conducted your research."
Nathan ShedroffDouble Your Mileage: Use Your Research Strategically
March 31, 2020
"Mobile browsers are typically updated with the OS, reducing variability compared to desktop browser versions."
Sam ProulxMobile Accessibility: Why Moving Accessibility Beyond the Desktop is Critical in a Mobile-first World
November 17, 2022
"You need clear roles for moderators, note takers, recruiters, and designers in a rapid research program."
Feleesha SterlingBuilding a Rapid Research Program (Videoconference)
May 18, 2023
"Starting with specific, meaningful priority communities rather than homogenized personas leads to powerful breakthroughs."
Neil BarrieWidening the Aperture: The Case for Taking a Broader Lens to the Dialogue between Products and Culture
March 25, 2024
"Incremental improvements and disruptive innovation require very different methods and measures."
John DevanneyThe Design Management Office
November 6, 2017
"You need to understand stakeholders’ fears, motivations, and incentives to change hearts and minds."
Katy MogalBut Do Your Insights Scale?
March 12, 2021